Vesicular monoamine transporter 2 and the acute and long-term response to 3,4-(±)-methylenedioxymethamphetamine. - Wikidata - awgldk - TriplyDB

Vesicular monoamine transporter 2 and the acute and long-term response to 3,4-(±)-methylenedioxymethamphetamine.

Vesicular monoamine transporter 2 and the acute and long-term response to 3,4-(±)-methylenedioxymethamphetamine.

http://www.wikidata.org/entity/Q34760266

about

Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications Effects of dextromethorphan on MDMA-induced serotonergic aberration in the brains of non-human primates using [123I]-ADAM/SPECT.Dopamine depleters in the treatment of hyperkinetic movement disorders.

P2860

Q26752602-E0EEE26D-0505-40F3-A006-1E5ED9CDEB1F Q37493467-C7B9A0A4-9EDA-40D9-A176-2FB3E4825A9F Q39000590-BFC3EB63-53F2-4C3A-B5A8-5F44D80DBCCC

P2860

Vesicular monoamine transporter 2 and the acute and long-term response to 3,4-(±)-methylenedioxymethamphetamine.

http://www.wikidata.org/entity/Q34760266

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Vesicular monoamine transporte ...... methylenedioxymethamphetamine.

@ast

Vesicular monoamine transporte ...... methylenedioxymethamphetamine.

@en

Vesicular monoamine transporte ...... methylenedioxymethamphetamine.

@nl

type

label

Vesicular monoamine transporte ...... methylenedioxymethamphetamine.

@ast

Vesicular monoamine transporte ...... methylenedioxymethamphetamine.

@en

Vesicular monoamine transporte ...... methylenedioxymethamphetamine.

@nl

prefLabel

Vesicular monoamine transporte ...... methylenedioxymethamphetamine.

@ast

Vesicular monoamine transporte ...... methylenedioxymethamphetamine.

@en

Vesicular monoamine transporte ...... methylenedioxymethamphetamine.

@nl

P1433

Q34760266-D01C68A1-6AEA-4DD3-A48F-C7E87E6253B7

P1476

Q34760266-8C9C542C-7F58-4630-BB40-A0CD3EDE69FD

P2093

Q34760266-09CC808D-4F24-45FB-92EE-EC61DF07D073

Q34760266-2375AC86-9ADE-457E-8212-08D3EBB9FE05

Q34760266-6A194B70-F0EB-4A20-9220-8DE8C4FF894A

Q34760266-A1879776-1A75-42F0-B56F-67C932D9E81D

Q34760266-D1656127-5FC6-44E7-A37F-9A5318AD577B

Q34760266-EAA7E927-60E3-42C4-B434-F2BB42D78244

P2860

Q34760266-00DF83D8-1B3E-415F-A33D-5E5E3E3A4DCB

Q34760266-07206D15-BD1C-4919-A269-258D1D32C32F

Q34760266-0A8C16E4-8181-4CBE-A110-86CA4DC3D454

Q34760266-0F3864DE-18CA-448D-B2C6-7CC2345B7F23

Q34760266-168DB09A-12C4-4912-8DBF-AB9FB482FB25

Q34760266-184CA1DF-4987-4148-ACF3-D308BBC6F6C4

Q34760266-1A95C63E-9E3A-4B9F-BC43-3129DCA1F392

Q34760266-25620F8A-8CD3-4793-9BAA-FD750BBA3430

Q34760266-271C7772-73A9-458E-BFA9-A85EF7143C62

Q34760266-3E3D8A37-A7CE-4966-B0EA-ACDC6D7F9E9B

P304

Q34760266-6E754B66-3567-490C-8783-C28C1FF49B4B

P31

Q34760266-536A2B72-C637-4300-9578-759006404451

P356

Q34760266-DB17DF00-495A-48A5-AAF8-B3026847487A

P433

Q34760266-5929FAAF-29F4-43EC-B751-88814972EBC1

P478

Q34760266-6F1A8805-74E2-4C95-A077-D70BBA667FC7

P577

Q34760266-067BB6B0-2EBD-4270-A180-0F82AD030489

P698

Q34760266-05F1B573-3F98-4FA0-92E7-58900069D575

P932

Q34760266-E513E18D-F04C-4F9F-AF97-5F87CE65E7AA

P356

P1433

Toxicological Sciences

P1476

Vesicular monoamine transporte ...... methylenedioxymethamphetamine.

@en

P2093

Andy V Phan

http://www.w3.org/2001/XMLSchema#string

Aram B Cholanians

http://www.w3.org/2001/XMLSchema#string

Joseph M Herndon

http://www.w3.org/2001/XMLSchema#string

Lucina E Lizarraga

http://www.w3.org/2001/XMLSchema#string

Serrine S Lau

http://www.w3.org/2001/XMLSchema#string

Terrence J Monks

http://www.w3.org/2001/XMLSchema#string

P2860

Transport mechanisms in acetylcholine and monoamine storage

Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum

The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats

The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain

Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata

The novel pyrrolidine nor-lobelane analog UKCP-110 [cis-2,5-di-(2-phenethyl)-pyrrolidine hydrochloride] inhibits VMAT2 function, methamphetamine-evoked dopamine release, and methamphetamine self-administration in rats.

Serotonin reuptake transporter deficiency modulates the acute thermoregulatory and locomotor activity response to 3,4-(±)-methylenedioxymethamphetamine, and attenuates depletions in serotonin levels in SERT-KO rats.

Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus.

Vmat2 heterozygous mutant mice display a depressive-like phenotype.

P304

209-219

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/TOXSCI/KFU222

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

143

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25370842

http://www.w3.org/2001/XMLSchema#string

P932

4274386

http://www.w3.org/2001/XMLSchema#string